Literature DB >> 9496731

Renal function in adult beta-thalassemia/Hb E disease.

L Ong-ajyooth1, P Malasit, S Ong-ajyooth, S Fucharoen, P Pootrakul, S Vasuvattakul, N Siritanaratkul, S Nilwarangkur.   

Abstract

Beta-Thalassemia hemoglobin E (beta-thal/Hb E) is the commonest form of hemoglobinopathy in Thailand. Shortened red cell life span, rapid iron turnover and tissue deposition of excess iron are major factors responsible for functional and physiological abnormalities found in various forms of thalassemia. Increased deposition of iron had been found in renal parenchyma of thalassemic patients, but no systematic study of the effect of the deposits on renal functions has been available. The purpose of this study is to describe the functional abnormalities of the kidney in patients with beta-thal/Hb E and provide evidence that increased oxidative stress might be one of the factors responsible for the damage. Urine and serum samples from 95 patients with beta-thal/Hb E were studied comparing with 27 age-matched healthy controls. No difference in the creatinine clearance was observed. beta-thal/Hb E patients excreted significantly more urinary protein (0.8+/-0.5 vs. 0.3+/-0.1 g/day, p < 0.001). Aminoaciduria was found in 16 % of the patients. Analysis of urinary protein by SDS-PAGE electrophoresis and silver staining revealed abnormal pattern of protein with increased small molecular weight (<45 kD) bands. Morning urine analysis showed significant lower urine osmolality (578.3+/-164.6 vs. 762.4+/-169.9 mosm/kg, p < 0.001) in patients. Patients excreted more NAG (N-acetyl beta-D-glucosaminidase, 26.3+/-41.3 vs. 8.4+/-3.9 U/g Cr, p < 0.0001) and beta2-microglobulin, 124.3+/-167 vs. 71+/-65.5 microg/g Cr, p = 0.001. Plasma and urine MDA (malonyldialdehyde) levels were both raised (p < 0.0001). Nine patients were selected for renal acidification study. All were found to be normal, but showed poor response to DDAVP challenge (urine osmolality 533+/-71). This is the first report of renal tubular defects found associated with beta-thal/Hb E disease. The mechanism leading to the damage is not known but it might be related to increased oxidative stress secondary to tissue deposition of iron, as indicated by the raised levels of serum and urine MDA. It is not known whether these functional defects would have any long-term effects on the patients. Further studies are warranted and means of prevention of these defects should urgently be sought.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9496731     DOI: 10.1159/000044904

Source DB:  PubMed          Journal:  Nephron        ISSN: 1660-8151            Impact factor:   2.847


  12 in total

1.  Indicators of Renal Glomerular and Tubular Functions in Patients with Beta-Thalassaemia Major: A cross sectional study at the Royal Hospital, Oman.

Authors:  Waad-Allah S Mula-Abed; Huda S Al-Hashmi; Muhanna N Al-Muslahi
Journal:  Sultan Qaboos Univ Med J       Date:  2011-02-12

2.  Early markers of renal dysfunction in patients with beta-thalassemia major.

Authors:  Masoumeh Mohkam; Bibi Shahin Shamsian; Atoosa Gharib; Shahin Nariman; Mohammad T Arzanian
Journal:  Pediatr Nephrol       Date:  2008-06       Impact factor: 3.714

3.  Renal functions in pediatric patients with beta-thalassemia major: relation to chelation therapy: original prospective study.

Authors:  Enas A Hamed; Nagla T ElMelegy
Journal:  Ital J Pediatr       Date:  2010-05-25       Impact factor: 2.638

4.  Renal function in children with beta-thalassemia major and thalassemia intermedia.

Authors:  Vladislav Smolkin; Raphael Halevy; Carina Levin; Miguel Mines; Waheeb Sakran; Katzap Ilia; Ariel Koren
Journal:  Pediatr Nephrol       Date:  2008-06-25       Impact factor: 3.714

5.  Renal tubule function in beta-thalassemia after hematopoietic stem cell transplantation.

Authors:  Achra Sumboonnanonda; Kleebsabai Sanpakit; Nuntawan Piyaphanee
Journal:  Pediatr Nephrol       Date:  2008-08-08       Impact factor: 3.714

6.  Magnetic resonance detection of kidney iron deposition in sickle cell disease: a marker of chronic hemolysis.

Authors:  Aaron Schein; Cathleen Enriquez; Thomas D Coates; John C Wood
Journal:  J Magn Reson Imaging       Date:  2008-09       Impact factor: 4.813

7.  Early Predictors of Renal Dysfunction in Egyptian Patients with β-Thalassemia Major and Intermedia.

Authors:  Azza A G Tantawy; Nagham El Bablawy; Amira A M Adly; Fatma S E Ebeid
Journal:  Mediterr J Hematol Infect Dis       Date:  2014-09-01       Impact factor: 2.576

8.  Glomerular and Tubular Functions in Transfusion-Dependent Thalassemia.

Authors:  Pathum Sookaromdee; Viroj Wiwanitkit
Journal:  Turk J Haematol       Date:  2018-03-08       Impact factor: 1.831

9.  Danshen (Salvia miltiorrhiza) injection suppresses kidney injury induced by iron overload in mice.

Authors:  Shengjiang Guan; Juanjuan Ma; Ying Zhang; Yonggang Gao; Yuanyuan Zhang; Xuan Zhang; Na Wang; Yun Xie; Jiangyan Wang; Jianping Zhang; Li Chu
Journal:  PLoS One       Date:  2013-09-16       Impact factor: 3.240

10.  Impaired acylcarnitine profile in transfusion-dependent beta-thalassemia major patients in Bangladesh.

Authors:  Suprovath Kumar Sarker; Md Tarikul Islam; Golam Sarower Bhuyan; Nusrat Sultana; Mst Noorjahan Begum; Mohammad Al Mahmud-Un-Nabi; Md Abdulla Al Noman Howladar; Tashmim Farhana Dipta; A K M Muraduzzaman; Syeda Kashfi Qadri; Tahmina Shirin; Salma Sadiya; Manzoor Hussain; Waqar Ahmed Khan; Sharif Akhteruzzaman; Syed Saleheen Qadri; Firdausi Qadri; Kaiissar Mannoor
Journal:  J Adv Res       Date:  2018-04-25       Impact factor: 10.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.